Skip to main content

Advertisement

Table 1 Characteristics of the Study Population.

From: Genetic variation in the NBS1, MRE11, RAD50 and BLM genes and susceptibility to non-Hodgkin lymphoma

   Cases (%) Controls (%)
Gender
  Male 463 (58%) 423 (53%)
  Female 334 (42%) 370 (47%)
Age group (years)
  20-49 150 (19%) 208 (26%)
  50-59 194 (24%) 169 (21%)
  60-69 214 (27%) 206 (26%)
  70+ 239 (30%) 210 (26%)
Ethnicity
  Caucasian 625 (78%) 613 (77%)
  Asian 80 (10%) 90 (11%)
  South Asian 29 (4%) 37 (5%)
  Mixed/Other 36 (5%) 34 (4%)
  Unknown/Refused 27 (3%) 19 (2%)
Pathology
   B-cell lymphomas
  DLBCL 210 (26%) -
  FL1 138 (17%) -
  FL2/FL3 78 (10%) -
  MZL/MALT 92 (12%) -
  MCL 47 (6%) -
  SLL/CLL 43 (5%) -
  LPL 42 (5%) -
  MISC BCL 71 (9%) -
   T-cell lymphomas
  MF 40 (5%) -
  PTCL 29 (4%) -
  MISC TCL 7 (1%) -
Total   797 (100%) 793 (100%)
  1. DLBCL = Diffuse Large B-Cell Lymphoma, FL = Follicular Lymphoma, FL1 = Follicular Lymphoma grade 1, FL2 = Follicular Lymphoma grade 2, FL3 = Follicular Lymphoma grade 3, MZ/MALT = Marginal Zone lymphoma/Mucosa-Associated Lymphoma Tissue lymphoma, MCL = Mantle Cell lymphoma, SLL = Small Lymphocytic Lymphoma, LPL = Lymphoplasmacytic Lymphoma, Misc. B-cell = Miscellaneous B-cell lymphoma, MF = Mycosis Fungoides, PTCL = Peripheral T-Cell Lymphoma, Misc. T-cell = Miscellaneous T-cell lymphoma.